Antimalarial agents diminish while methotrexate, azathioprine and mycophenolic acid increase BAFF levels in systemic lupus erythematosus

被引：14

作者：

Hernandez-Breijo, Borja ^{[1
]}

Gomez, Alvaro ^{[2
,3
]}

Soukka, Sofia ^{[2
,3
]}

Johansson, Petter ^{[2
,3
]}

Parodis, Ioannis ^{[2
,3
]}

机构：

[1] La Paz Univ Hosp, IdiPaz, Immunorheumatol Res Grp, Madrid, Spain

[2] Karolinska Inst, Dept Med Solna, Div Rheumatol, Stockholm, Sweden

[3] Karolinska Univ Hosp, Rheumatol, SE-17176 Stockholm, Sweden

来源：

AUTOIMMUNITY REVIEWS | 2019年 / 18卷 / 10期

基金：

瑞典研究理事会;

关键词：

Systemic lupus erythematosus; BAFF; BLyS; Antimalarial agents; Immunosuppressive agents; B-LYMPHOCYTE STIMULATOR; DISEASE-ACTIVITY; HYDROXYCHLOROQUINE; MECHANISMS; BELIMUMAB;

D O I：

10.1016/j.autrev.2019.102372

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页数：4

共 17 条

[1] EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics [J].

Bertsias, G. ;

Ioannidis, J. P. A. ;

Boletis, J. ;

Bombardieri, S. ;

Cervera, R. ;

Dostal, C. ;

Font, J. ;

Gilboe, I. M. ;

Houssiau, F. ;

Huizinga, T. ;

Isenberg, D. ;

Kallenberg, C. G. M. ;

Khamashta, M. ;

Piette, J. C. ;

Schneider, M. ;

Smolen, J. ;

Sturfelt, G. ;

Tincani, A. ;

van Vollenhoven, R. ;

Gordon, C. ;

Boumpas, D. T. .

ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) :195-205

[2]

Bosello S, 2008, J RHEUMATOL, V35, P1256

[3]

Fox R, 1996, LUPUS, V5, pS4, DOI 10.1177/096120339600500103

[4] A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus [J].

Furie, Richard ;

Petri, Michelle ;

Zamani, Omid ;

Cervera, Ricard ;

Wallace, Daniel J. ;

Tegzova, Dana ;

Sanchez-Guerrero, Jorge ;

Schwarting, Andreas ;

Merrill, Joan T. ;

Chatham, W. Winn ;

Stohl, William ;

Ginzler, Ellen M. ;

Hough, Douglas R. ;

Zhong, Z. John ;

Freimuth, William ;

van Vollenhoven, Ronald F. .

ARTHRITIS AND RHEUMATISM, 2011, 63 (12) :3918-3930

[5] Distinct Effects of Methotrexate and Etanercept on the B Cell Compartment in Patients With Juvenile Idiopathic Arthritis [J].

Glaesener, Stephanie ;

Quach, Tam D. ;

Onken, Nils ;

Weller-Heinemann, Frank ;

Dressler, Frank ;

Huppertz, Hans-Iko ;

Thon, Angelika ;

Meyer-Bahlburg, Almut .

ARTHRITIS & RHEUMATOLOGY, 2014, 66 (09) :2590-2600

[6] New concepts in antimalarial use and mode of action in dermatology [J].

Kalia, Sunil ;

Dutz, Jan P. .

DERMATOLOGIC THERAPY, 2007, 20 (04) :160-174

[7] The role of antimalarial agents in the treatment of SLE and lupus nephritis [J].

Lee, Senq-J ;

Silverman, Earl ;

Bargman, Joanne M. .

NATURE REVIEWS NEPHROLOGY, 2011, 7 (12) :718-729

[8]

Mahdy A. A., 2014, Bulletin of the Faculty of Pharmacy, Cairo University, V52, P37, DOI 10.1016/j.bfopcu.2014.01.002

[9] Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial [J].

Navarra, Sandra V. ;

Guzman, Renato M. ;

Gallacher, Alberto E. ;

Hall, Stephen ;

Levy, Roger A. ;

Jimenez, Renato E. ;

Li, Edmund K-M ;

Thomas, Mathew ;

Kim, Ho-Youn ;

Leon, Manuel G. ;

Tanasescu, Coman ;

Nasonov, Eugeny ;

Lan, Joung-Liang ;

Pineda, Lilia ;

Zhong, Z. John ;

Freimuth, William ;

Petri, Michelle A. .

LANCET, 2011, 377 (9767) :721-731

[10] Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus - distinct roles of BAFF and APRIL [J].

Parodis, I. ;

Soder, F. ;

Faustini, F. ;

Kasza, Z. ;

Samuelsson, I. ;

Zickert, A. ;

Svenungsson, E. ;

van Vollenhoven, R. F. ;

Malmstrom, V. ;

Wermeling, F. ;

Gunnarsson, I. .

LUPUS, 2018, 27 (09) :1470-1478

← 1 2 →